SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-015812
Filing Date
2024-04-24
Accepted
2024-04-24 17:00:26
Documents
1
Period of Report
2024-04-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6303
  Complete submission text file 0001493152-24-015812.txt   7810
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Issuer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 32 CROUCH HALL LANE ST. ALBANS X0 AL3 7EU
Business Address
Tapolczay David (Reporting) CIK: 0001991789 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41245 | Film No.: 24871366